CD4+/CD8+ lymphocyte ratio as a biomarker of morbidity and severity in patients with moderate and severe COVID-19

CD4+/CD8+ lymphocyte ratio as a biomarker of morbidity and severity in patients with moderate and severe COVID-19

Abstract The assessment of lymphocyte populations allows the monitoring, follow-up and treatment of patients with various infectious diseases. Acute respiratory syndrome caused by coronavirus (SARS-CoV-2), can lead to a decrease in circulating lymphocytes and cause disease progression and severity....

Full description

Saved in:
Bibliographic Details
Main Authors: D. Torres-Gonzales, E. Colona-Vallejos, L. Alzamora-Gonzales, G. Tineo Pozo, E. Chamorro Chirinos, C. Lorenzo Quito, M. Aliaga Zamudio, E. Cambillo Moyano, E. E. Aguirre-Siancas, E. Ruiz Ramirez
Format: Article
Language:English
Published: Instituto Internacional de Ecologia 2025-07-01
Series:Brazilian Journal of Biology
Subjects:
CD4+
CD8+
COVID-19
SARS-CoV-2
CD4+/CD8+ ratio
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1519-69842025000100274&lng=en&tlng=en
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items